Is Pro-Dex Inc (PDEX) overvalued? · P/E 16, rev $66.6M
Pro-Dex Inc (PDEX) is a medical instruments & supplies company listed on US.
This page asks whether Pro-Dex Inc (PDEX) looks expensive on cached numbers — not a short thesis.
Latest reported PDEX revenue for 2025-06-30 was $66.6M. Net income was $155.0K. Revenue was up 23.7% from 2024-06-30 to 2025-06-30. PDEX currently screens at market cap $146.4M and trailing P/E 16.3.
PDEX currently screens at market cap $146.4M and trailing P/E 16.3. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next PDEX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the PDEX stock page for the full model, not this heading.
Not investment advice.